Promyco Diagnostics · raw details

High-risk Pregnancy Assessment · Jerusalem · Founded 2008

inactive Pre-Funding ← back to profile

About

High-risk Pregnancy Assessment

Promyco Diagnostics has developed a simple and noninvasive serology diagnostic kit for the detection of urogenital Mycoplasma infection to assess women for theirrisk of developing pregnancy complications. Promyco Diagnostics has found a way to address the unique characteristics of the bacteria, mainly antigenic variation, that make it hard to develop an efficient serology diagnostic test. Promyco Diagnostics developed a new assay based on a patent-protected mixture of mycoplasmal components (antigens). This antigen cocktail was carefully selected from Mycoplasma isolated from patients with active inflammation, resulting in a highly sensitive and specific serology test.

Identity

NamePromyco Diagnostics
Slugpromyco-diagnostics
Type / kindstartup
Crunchbase IDpromyco-diagnostics
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6E-7YKDA

Status

Statusinactive
Status reasonNon Active, Jan 2015
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtJerusalem District
HQ cityJerusalem
HQ addressJerusalem, Israel

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareConsumersDemographics & FamilyWomen
Business models
B2B
Tags
medical-devicesgynecologypregnancymedical-productswomen-healthdiagnostics

Funding

Total raised
Current stagePre-Funding

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}